Re: Two big thank you’s

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Two big thank you’s

in response to

Re: Two big thank you’s

jonzobot

posted on Nov 25, 2022 07:18AM

jonzobot, would it be easier just to sell the zenith shares now into the market which may allow you to take a capital loss and buy them back 30 days hence directly into a TFSA account. Assuming your ultimate goal is to transfer your existing Zenith shares into a TFSA account. This would avoid any overcontribution uncertainties.